nodes	percent_of_prediction	percent_of_DWPC	metapath
Dantrolene—CYP3A4—Methylprednisolone—psoriatic arthritis	0.127	0.248	CbGbCtD
Dantrolene—CYP3A4—Triamcinolone—psoriatic arthritis	0.0965	0.188	CbGbCtD
Dantrolene—CYP3A4—Betamethasone—psoriatic arthritis	0.0828	0.161	CbGbCtD
Dantrolene—CYP3A4—Prednisolone—psoriatic arthritis	0.0817	0.159	CbGbCtD
Dantrolene—CYP3A4—Prednisone—psoriatic arthritis	0.0771	0.15	CbGbCtD
Dantrolene—CYP3A4—Dexamethasone—psoriatic arthritis	0.0482	0.0938	CbGbCtD
Dantrolene—Gastrointestinal haemorrhage—Prednisone—psoriatic arthritis	0.00181	0.00372	CcSEcCtD
Dantrolene—Thrombophlebitis—Methotrexate—psoriatic arthritis	0.00174	0.00359	CcSEcCtD
Dantrolene—Haemoglobin—Prednisolone—psoriatic arthritis	0.00173	0.00356	CcSEcCtD
Dantrolene—Haemorrhage—Prednisolone—psoriatic arthritis	0.00172	0.00354	CcSEcCtD
Dantrolene—Sweating—Methylprednisolone—psoriatic arthritis	0.00169	0.00347	CcSEcCtD
Dantrolene—Hepatic failure—Methotrexate—psoriatic arthritis	0.00168	0.00346	CcSEcCtD
Dantrolene—Visual impairment—Prednisolone—psoriatic arthritis	0.00166	0.00341	CcSEcCtD
Dantrolene—Muscular weakness—Prednisone—psoriatic arthritis	0.00159	0.00328	CcSEcCtD
Dantrolene—Visual disturbance—Methotrexate—psoriatic arthritis	0.00159	0.00328	CcSEcCtD
Dantrolene—Haemoglobin—Triamcinolone—psoriatic arthritis	0.00159	0.00327	CcSEcCtD
Dantrolene—Haemoglobin—Methylprednisolone—psoriatic arthritis	0.00159	0.00326	CcSEcCtD
Dantrolene—Haemorrhage—Triamcinolone—psoriatic arthritis	0.00158	0.00325	CcSEcCtD
Dantrolene—Haemorrhage—Methylprednisolone—psoriatic arthritis	0.00158	0.00325	CcSEcCtD
Dantrolene—Visual impairment—Methylprednisolone—psoriatic arthritis	0.00152	0.00313	CcSEcCtD
Dantrolene—Erythema—Prednisolone—psoriatic arthritis	0.0015	0.00308	CcSEcCtD
Dantrolene—Haemoglobin—Betamethasone—psoriatic arthritis	0.00144	0.00297	CcSEcCtD
Dantrolene—Haemoglobin—Dexamethasone—psoriatic arthritis	0.00144	0.00297	CcSEcCtD
Dantrolene—Haemorrhage—Betamethasone—psoriatic arthritis	0.00144	0.00295	CcSEcCtD
Dantrolene—Haemorrhage—Dexamethasone—psoriatic arthritis	0.00144	0.00295	CcSEcCtD
Dantrolene—Vision blurred—Prednisolone—psoriatic arthritis	0.00141	0.0029	CcSEcCtD
Dantrolene—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.00139	0.00286	CcSEcCtD
Dantrolene—Depression—Prednisone—psoriatic arthritis	0.00139	0.00286	CcSEcCtD
Dantrolene—Visual impairment—Betamethasone—psoriatic arthritis	0.00138	0.00285	CcSEcCtD
Dantrolene—Visual impairment—Dexamethasone—psoriatic arthritis	0.00138	0.00285	CcSEcCtD
Dantrolene—Erythema—Triamcinolone—psoriatic arthritis	0.00138	0.00283	CcSEcCtD
Dantrolene—Erythema—Methylprednisolone—psoriatic arthritis	0.00137	0.00283	CcSEcCtD
Dantrolene—Malaise—Prednisolone—psoriatic arthritis	0.00135	0.00278	CcSEcCtD
Dantrolene—Dysgeusia—Triamcinolone—psoriatic arthritis	0.00135	0.00277	CcSEcCtD
Dantrolene—Back pain—Triamcinolone—psoriatic arthritis	0.00133	0.00274	CcSEcCtD
Dantrolene—Convulsion—Prednisolone—psoriatic arthritis	0.0013	0.00267	CcSEcCtD
Dantrolene—Hypertension—Prednisolone—psoriatic arthritis	0.00129	0.00266	CcSEcCtD
Dantrolene—Eosinophilia—Methotrexate—psoriatic arthritis	0.00129	0.00266	CcSEcCtD
Dantrolene—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.00128	0.00263	CcSEcCtD
Dantrolene—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.00128	0.00262	CcSEcCtD
Dantrolene—Discomfort—Prednisolone—psoriatic arthritis	0.00126	0.00259	CcSEcCtD
Dantrolene—Haemoglobin—Prednisone—psoriatic arthritis	0.00126	0.00258	CcSEcCtD
Dantrolene—Haemorrhage—Prednisone—psoriatic arthritis	0.00125	0.00257	CcSEcCtD
Dantrolene—Erythema—Betamethasone—psoriatic arthritis	0.00125	0.00257	CcSEcCtD
Dantrolene—Erythema—Dexamethasone—psoriatic arthritis	0.00125	0.00257	CcSEcCtD
Dantrolene—Malaise—Triamcinolone—psoriatic arthritis	0.00124	0.00255	CcSEcCtD
Dantrolene—Malaise—Methylprednisolone—psoriatic arthritis	0.00124	0.00255	CcSEcCtD
Dantrolene—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00122	0.00251	CcSEcCtD
Dantrolene—Convulsion—Triamcinolone—psoriatic arthritis	0.00119	0.00245	CcSEcCtD
Dantrolene—Tachycardia—Prednisolone—psoriatic arthritis	0.00119	0.00245	CcSEcCtD
Dantrolene—Convulsion—Methylprednisolone—psoriatic arthritis	0.00119	0.00245	CcSEcCtD
Dantrolene—Hypertension—Triamcinolone—psoriatic arthritis	0.00119	0.00245	CcSEcCtD
Dantrolene—Hypertension—Methylprednisolone—psoriatic arthritis	0.00119	0.00244	CcSEcCtD
Dantrolene—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00118	0.00243	CcSEcCtD
Dantrolene—Myalgia—Triamcinolone—psoriatic arthritis	0.00117	0.00241	CcSEcCtD
Dantrolene—Myalgia—Methylprednisolone—psoriatic arthritis	0.00117	0.00241	CcSEcCtD
Dantrolene—Drowsiness—Methotrexate—psoriatic arthritis	0.00116	0.00239	CcSEcCtD
Dantrolene—Depression—Methotrexate—psoriatic arthritis	0.00116	0.00239	CcSEcCtD
Dantrolene—Flushing—Prednisone—psoriatic arthritis	0.00116	0.00239	CcSEcCtD
Dantrolene—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00116	0.00238	CcSEcCtD
Dantrolene—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00116	0.00238	CcSEcCtD
Dantrolene—Discomfort—Triamcinolone—psoriatic arthritis	0.00116	0.00238	CcSEcCtD
Dantrolene—Discomfort—Methylprednisolone—psoriatic arthritis	0.00116	0.00238	CcSEcCtD
Dantrolene—Dry mouth—Triamcinolone—psoriatic arthritis	0.00115	0.00236	CcSEcCtD
Dantrolene—Renal failure—Methotrexate—psoriatic arthritis	0.00114	0.00235	CcSEcCtD
Dantrolene—Confusional state—Methylprednisolone—psoriatic arthritis	0.00113	0.00233	CcSEcCtD
Dantrolene—Malaise—Dexamethasone—psoriatic arthritis	0.00113	0.00232	CcSEcCtD
Dantrolene—Malaise—Betamethasone—psoriatic arthritis	0.00113	0.00232	CcSEcCtD
Dantrolene—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00112	0.00231	CcSEcCtD
Dantrolene—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00112	0.00231	CcSEcCtD
Dantrolene—Sweating—Methotrexate—psoriatic arthritis	0.00112	0.00229	CcSEcCtD
Dantrolene—Haematuria—Methotrexate—psoriatic arthritis	0.00111	0.00228	CcSEcCtD
Dantrolene—Insomnia—Prednisolone—psoriatic arthritis	0.00111	0.00227	CcSEcCtD
Dantrolene—Tachycardia—Triamcinolone—psoriatic arthritis	0.0011	0.00226	CcSEcCtD
Dantrolene—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00109	0.00225	CcSEcCtD
Dantrolene—Erythema—Prednisone—psoriatic arthritis	0.00109	0.00224	CcSEcCtD
Dantrolene—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00109	0.00223	CcSEcCtD
Dantrolene—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00108	0.00223	CcSEcCtD
Dantrolene—Convulsion—Dexamethasone—psoriatic arthritis	0.00108	0.00223	CcSEcCtD
Dantrolene—Convulsion—Betamethasone—psoriatic arthritis	0.00108	0.00223	CcSEcCtD
Dantrolene—Hypertension—Dexamethasone—psoriatic arthritis	0.00108	0.00222	CcSEcCtD
Dantrolene—Hypertension—Betamethasone—psoriatic arthritis	0.00108	0.00222	CcSEcCtD
Dantrolene—Myalgia—Dexamethasone—psoriatic arthritis	0.00106	0.00219	CcSEcCtD
Dantrolene—Myalgia—Betamethasone—psoriatic arthritis	0.00106	0.00219	CcSEcCtD
Dantrolene—Discomfort—Dexamethasone—psoriatic arthritis	0.00105	0.00216	CcSEcCtD
Dantrolene—Discomfort—Betamethasone—psoriatic arthritis	0.00105	0.00216	CcSEcCtD
Dantrolene—Haemoglobin—Methotrexate—psoriatic arthritis	0.00105	0.00216	CcSEcCtD
Dantrolene—Pain—Prednisolone—psoriatic arthritis	0.00105	0.00215	CcSEcCtD
Dantrolene—Hepatitis—Methotrexate—psoriatic arthritis	0.00104	0.00215	CcSEcCtD
Dantrolene—Haemorrhage—Methotrexate—psoriatic arthritis	0.00104	0.00215	CcSEcCtD
Dantrolene—Vision blurred—Prednisone—psoriatic arthritis	0.00103	0.00211	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00102	0.00211	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00102	0.0021	CcSEcCtD
Dantrolene—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00102	0.0021	CcSEcCtD
Dantrolene—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00102	0.0021	CcSEcCtD
Dantrolene—Insomnia—Triamcinolone—psoriatic arthritis	0.00102	0.00209	CcSEcCtD
Dantrolene—Insomnia—Methylprednisolone—psoriatic arthritis	0.00101	0.00209	CcSEcCtD
Dantrolene—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00101	0.00208	CcSEcCtD
Dantrolene—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00101	0.00207	CcSEcCtD
Dantrolene—Visual impairment—Methotrexate—psoriatic arthritis	0.00101	0.00207	CcSEcCtD
Dantrolene—Anaemia—Prednisone—psoriatic arthritis	0.00101	0.00207	CcSEcCtD
Dantrolene—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000999	0.00205	CcSEcCtD
Dantrolene—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000999	0.00205	CcSEcCtD
Dantrolene—Tachycardia—Betamethasone—psoriatic arthritis	0.000996	0.00205	CcSEcCtD
Dantrolene—Tachycardia—Dexamethasone—psoriatic arthritis	0.000996	0.00205	CcSEcCtD
Dantrolene—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00099	0.00203	CcSEcCtD
Dantrolene—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000987	0.00203	CcSEcCtD
Dantrolene—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000986	0.00203	CcSEcCtD
Dantrolene—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000986	0.00203	CcSEcCtD
Dantrolene—Malaise—Prednisone—psoriatic arthritis	0.000982	0.00202	CcSEcCtD
Dantrolene—Anorexia—Dexamethasone—psoriatic arthritis	0.000972	0.002	CcSEcCtD
Dantrolene—Anorexia—Betamethasone—psoriatic arthritis	0.000972	0.002	CcSEcCtD
Dantrolene—Urticaria—Prednisolone—psoriatic arthritis	0.000971	0.002	CcSEcCtD
Dantrolene—Fatigue—Triamcinolone—psoriatic arthritis	0.000969	0.00199	CcSEcCtD
Dantrolene—Fatigue—Methylprednisolone—psoriatic arthritis	0.000967	0.00199	CcSEcCtD
Dantrolene—Pain—Triamcinolone—psoriatic arthritis	0.000961	0.00198	CcSEcCtD
Dantrolene—Convulsion—Prednisone—psoriatic arthritis	0.000943	0.00194	CcSEcCtD
Dantrolene—Hypertension—Prednisone—psoriatic arthritis	0.00094	0.00193	CcSEcCtD
Dantrolene—Chills—Methotrexate—psoriatic arthritis	0.000938	0.00193	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000929	0.00191	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000929	0.00191	CcSEcCtD
Dantrolene—Myalgia—Prednisone—psoriatic arthritis	0.000927	0.00191	CcSEcCtD
Dantrolene—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000926	0.0019	CcSEcCtD
Dantrolene—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000924	0.0019	CcSEcCtD
Dantrolene—Insomnia—Dexamethasone—psoriatic arthritis	0.000923	0.0019	CcSEcCtD
Dantrolene—Insomnia—Betamethasone—psoriatic arthritis	0.000923	0.0019	CcSEcCtD
Dantrolene—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000917	0.00189	CcSEcCtD
Dantrolene—Discomfort—Prednisone—psoriatic arthritis	0.000916	0.00188	CcSEcCtD
Dantrolene—Erythema—Methotrexate—psoriatic arthritis	0.00091	0.00187	CcSEcCtD
Dantrolene—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000901	0.00185	CcSEcCtD
Dantrolene—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000898	0.00185	CcSEcCtD
Dantrolene—Dyspepsia—Betamethasone—psoriatic arthritis	0.000898	0.00185	CcSEcCtD
Dantrolene—Urticaria—Triamcinolone—psoriatic arthritis	0.000893	0.00184	CcSEcCtD
Dantrolene—Urticaria—Methylprednisolone—psoriatic arthritis	0.000891	0.00183	CcSEcCtD
Dantrolene—Dysgeusia—Methotrexate—psoriatic arthritis	0.000891	0.00183	CcSEcCtD
Dantrolene—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000889	0.00183	CcSEcCtD
Dantrolene—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000888	0.00183	CcSEcCtD
Dantrolene—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000887	0.00182	CcSEcCtD
Dantrolene—Decreased appetite—Betamethasone—psoriatic arthritis	0.000887	0.00182	CcSEcCtD
Dantrolene—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000887	0.00182	CcSEcCtD
Dantrolene—Back pain—Methotrexate—psoriatic arthritis	0.00088	0.00181	CcSEcCtD
Dantrolene—Fatigue—Dexamethasone—psoriatic arthritis	0.000879	0.00181	CcSEcCtD
Dantrolene—Fatigue—Betamethasone—psoriatic arthritis	0.000879	0.00181	CcSEcCtD
Dantrolene—Pain—Dexamethasone—psoriatic arthritis	0.000872	0.00179	CcSEcCtD
Dantrolene—Pain—Betamethasone—psoriatic arthritis	0.000872	0.00179	CcSEcCtD
Dantrolene—Tachycardia—Prednisone—psoriatic arthritis	0.000867	0.00178	CcSEcCtD
Dantrolene—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000859	0.00177	CcSEcCtD
Dantrolene—Vision blurred—Methotrexate—psoriatic arthritis	0.000857	0.00176	CcSEcCtD
Dantrolene—Anorexia—Prednisone—psoriatic arthritis	0.000847	0.00174	CcSEcCtD
Dantrolene—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000844	0.00174	CcSEcCtD
Dantrolene—Anaemia—Methotrexate—psoriatic arthritis	0.000841	0.00173	CcSEcCtD
Dantrolene—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000841	0.00173	CcSEcCtD
Dantrolene—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000841	0.00173	CcSEcCtD
Dantrolene—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000834	0.00172	CcSEcCtD
Dantrolene—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000834	0.00172	CcSEcCtD
Dantrolene—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000828	0.0017	CcSEcCtD
Dantrolene—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000826	0.0017	CcSEcCtD
Dantrolene—Malaise—Methotrexate—psoriatic arthritis	0.00082	0.00169	CcSEcCtD
Dantrolene—Leukopenia—Methotrexate—psoriatic arthritis	0.000814	0.00167	CcSEcCtD
Dantrolene—Urticaria—Dexamethasone—psoriatic arthritis	0.00081	0.00167	CcSEcCtD
Dantrolene—Urticaria—Betamethasone—psoriatic arthritis	0.00081	0.00167	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000809	0.00166	CcSEcCtD
Dantrolene—Dizziness—Prednisolone—psoriatic arthritis	0.000808	0.00166	CcSEcCtD
Dantrolene—Asthenia—Triamcinolone—psoriatic arthritis	0.000807	0.00166	CcSEcCtD
Dantrolene—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000806	0.00166	CcSEcCtD
Dantrolene—Abdominal pain—Betamethasone—psoriatic arthritis	0.000806	0.00166	CcSEcCtD
Dantrolene—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000806	0.00166	CcSEcCtD
Dantrolene—Body temperature increased—Betamethasone—psoriatic arthritis	0.000806	0.00166	CcSEcCtD
Dantrolene—Asthenia—Methylprednisolone—psoriatic arthritis	0.000805	0.00165	CcSEcCtD
Dantrolene—Insomnia—Prednisone—psoriatic arthritis	0.000803	0.00165	CcSEcCtD
Dantrolene—Pruritus—Triamcinolone—psoriatic arthritis	0.000795	0.00164	CcSEcCtD
Dantrolene—Pruritus—Methylprednisolone—psoriatic arthritis	0.000794	0.00163	CcSEcCtD
Dantrolene—Convulsion—Methotrexate—psoriatic arthritis	0.000788	0.00162	CcSEcCtD
Dantrolene—Dyspepsia—Prednisone—psoriatic arthritis	0.000782	0.00161	CcSEcCtD
Dantrolene—Myalgia—Methotrexate—psoriatic arthritis	0.000774	0.00159	CcSEcCtD
Dantrolene—Decreased appetite—Prednisone—psoriatic arthritis	0.000772	0.00159	CcSEcCtD
Dantrolene—Rash—Prednisolone—psoriatic arthritis	0.000771	0.00158	CcSEcCtD
Dantrolene—Dermatitis—Prednisolone—psoriatic arthritis	0.00077	0.00158	CcSEcCtD
Dantrolene—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000767	0.00158	CcSEcCtD
Dantrolene—Fatigue—Prednisone—psoriatic arthritis	0.000766	0.00157	CcSEcCtD
Dantrolene—Headache—Prednisolone—psoriatic arthritis	0.000766	0.00157	CcSEcCtD
Dantrolene—Discomfort—Methotrexate—psoriatic arthritis	0.000765	0.00157	CcSEcCtD
Dantrolene—Constipation—Prednisone—psoriatic arthritis	0.00076	0.00156	CcSEcCtD
Dantrolene—Confusional state—Methotrexate—psoriatic arthritis	0.000749	0.00154	CcSEcCtD
Dantrolene—Dizziness—Triamcinolone—psoriatic arthritis	0.000743	0.00153	CcSEcCtD
Dantrolene—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000742	0.00153	CcSEcCtD
Dantrolene—Dizziness—Methylprednisolone—psoriatic arthritis	0.000742	0.00153	CcSEcCtD
Dantrolene—Feeling abnormal—Prednisone—psoriatic arthritis	0.000732	0.00151	CcSEcCtD
Dantrolene—Asthenia—Dexamethasone—psoriatic arthritis	0.000732	0.0015	CcSEcCtD
Dantrolene—Asthenia—Betamethasone—psoriatic arthritis	0.000732	0.0015	CcSEcCtD
Dantrolene—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000727	0.00149	CcSEcCtD
Dantrolene—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000726	0.00149	CcSEcCtD
Dantrolene—Nausea—Prednisolone—psoriatic arthritis	0.000726	0.00149	CcSEcCtD
Dantrolene—Pruritus—Betamethasone—psoriatic arthritis	0.000722	0.00148	CcSEcCtD
Dantrolene—Pruritus—Dexamethasone—psoriatic arthritis	0.000722	0.00148	CcSEcCtD
Dantrolene—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000718	0.00148	CcSEcCtD
Dantrolene—Vomiting—Triamcinolone—psoriatic arthritis	0.000715	0.00147	CcSEcCtD
Dantrolene—Vomiting—Methylprednisolone—psoriatic arthritis	0.000713	0.00147	CcSEcCtD
Dantrolene—Rash—Triamcinolone—psoriatic arthritis	0.000709	0.00146	CcSEcCtD
Dantrolene—Dermatitis—Triamcinolone—psoriatic arthritis	0.000708	0.00146	CcSEcCtD
Dantrolene—Anorexia—Methotrexate—psoriatic arthritis	0.000708	0.00146	CcSEcCtD
Dantrolene—Rash—Methylprednisolone—psoriatic arthritis	0.000707	0.00145	CcSEcCtD
Dantrolene—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000707	0.00145	CcSEcCtD
Dantrolene—Urticaria—Prednisone—psoriatic arthritis	0.000706	0.00145	CcSEcCtD
Dantrolene—Headache—Triamcinolone—psoriatic arthritis	0.000704	0.00145	CcSEcCtD
Dantrolene—Headache—Methylprednisolone—psoriatic arthritis	0.000703	0.00144	CcSEcCtD
Dantrolene—Abdominal pain—Prednisone—psoriatic arthritis	0.000702	0.00144	CcSEcCtD
Dantrolene—Body temperature increased—Prednisone—psoriatic arthritis	0.000702	0.00144	CcSEcCtD
Dantrolene—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000698	0.00144	CcSEcCtD
Dantrolene—Diarrhoea—Betamethasone—psoriatic arthritis	0.000698	0.00144	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000676	0.00139	CcSEcCtD
Dantrolene—Dizziness—Dexamethasone—psoriatic arthritis	0.000675	0.00139	CcSEcCtD
Dantrolene—Dizziness—Betamethasone—psoriatic arthritis	0.000675	0.00139	CcSEcCtD
Dantrolene—Insomnia—Methotrexate—psoriatic arthritis	0.000671	0.00138	CcSEcCtD
Dantrolene—Nausea—Triamcinolone—psoriatic arthritis	0.000668	0.00137	CcSEcCtD
Dantrolene—Nausea—Methylprednisolone—psoriatic arthritis	0.000666	0.00137	CcSEcCtD
Dantrolene—Somnolence—Methotrexate—psoriatic arthritis	0.00066	0.00136	CcSEcCtD
Dantrolene—Hypersensitivity—Prednisone—psoriatic arthritis	0.000655	0.00135	CcSEcCtD
Dantrolene—Dyspepsia—Methotrexate—psoriatic arthritis	0.000654	0.00134	CcSEcCtD
Dantrolene—Vomiting—Betamethasone—psoriatic arthritis	0.000649	0.00133	CcSEcCtD
Dantrolene—Vomiting—Dexamethasone—psoriatic arthritis	0.000649	0.00133	CcSEcCtD
Dantrolene—Decreased appetite—Methotrexate—psoriatic arthritis	0.000645	0.00133	CcSEcCtD
Dantrolene—Rash—Betamethasone—psoriatic arthritis	0.000643	0.00132	CcSEcCtD
Dantrolene—Rash—Dexamethasone—psoriatic arthritis	0.000643	0.00132	CcSEcCtD
Dantrolene—Dermatitis—Betamethasone—psoriatic arthritis	0.000643	0.00132	CcSEcCtD
Dantrolene—Dermatitis—Dexamethasone—psoriatic arthritis	0.000643	0.00132	CcSEcCtD
Dantrolene—Fatigue—Methotrexate—psoriatic arthritis	0.00064	0.00132	CcSEcCtD
Dantrolene—Headache—Dexamethasone—psoriatic arthritis	0.000639	0.00131	CcSEcCtD
Dantrolene—Headache—Betamethasone—psoriatic arthritis	0.000639	0.00131	CcSEcCtD
Dantrolene—Asthenia—Prednisone—psoriatic arthritis	0.000637	0.00131	CcSEcCtD
Dantrolene—Pain—Methotrexate—psoriatic arthritis	0.000635	0.00131	CcSEcCtD
Dantrolene—Pruritus—Prednisone—psoriatic arthritis	0.000629	0.00129	CcSEcCtD
Dantrolene—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000612	0.00126	CcSEcCtD
Dantrolene—Diarrhoea—Prednisone—psoriatic arthritis	0.000608	0.00125	CcSEcCtD
Dantrolene—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000607	0.00125	CcSEcCtD
Dantrolene—Nausea—Betamethasone—psoriatic arthritis	0.000606	0.00125	CcSEcCtD
Dantrolene—Nausea—Dexamethasone—psoriatic arthritis	0.000606	0.00125	CcSEcCtD
Dantrolene—Urticaria—Methotrexate—psoriatic arthritis	0.00059	0.00121	CcSEcCtD
Dantrolene—Dizziness—Prednisone—psoriatic arthritis	0.000587	0.00121	CcSEcCtD
Dantrolene—Body temperature increased—Methotrexate—psoriatic arthritis	0.000587	0.00121	CcSEcCtD
Dantrolene—Abdominal pain—Methotrexate—psoriatic arthritis	0.000587	0.00121	CcSEcCtD
Dantrolene—Vomiting—Prednisone—psoriatic arthritis	0.000565	0.00116	CcSEcCtD
Dantrolene—Rash—Prednisone—psoriatic arthritis	0.00056	0.00115	CcSEcCtD
Dantrolene—Dermatitis—Prednisone—psoriatic arthritis	0.00056	0.00115	CcSEcCtD
Dantrolene—Headache—Prednisone—psoriatic arthritis	0.000557	0.00114	CcSEcCtD
Dantrolene—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000547	0.00112	CcSEcCtD
Dantrolene—Asthenia—Methotrexate—psoriatic arthritis	0.000533	0.0011	CcSEcCtD
Dantrolene—Nausea—Prednisone—psoriatic arthritis	0.000528	0.00109	CcSEcCtD
Dantrolene—Pruritus—Methotrexate—psoriatic arthritis	0.000525	0.00108	CcSEcCtD
Dantrolene—Diarrhoea—Methotrexate—psoriatic arthritis	0.000508	0.00104	CcSEcCtD
Dantrolene—Dizziness—Methotrexate—psoriatic arthritis	0.000491	0.00101	CcSEcCtD
Dantrolene—Vomiting—Methotrexate—psoriatic arthritis	0.000472	0.000971	CcSEcCtD
Dantrolene—Rash—Methotrexate—psoriatic arthritis	0.000468	0.000963	CcSEcCtD
Dantrolene—Dermatitis—Methotrexate—psoriatic arthritis	0.000468	0.000962	CcSEcCtD
Dantrolene—Headache—Methotrexate—psoriatic arthritis	0.000465	0.000956	CcSEcCtD
Dantrolene—Nausea—Methotrexate—psoriatic arthritis	0.000441	0.000907	CcSEcCtD
